Medtronic receives CE mark for Micra AV Pacemaker
This pacemaker is exceptionally minimally invasive, and has less potential to cause complications than other devices. Photo courtesy of Medgadget.

Medtronic has received a CE mark for its Micra AV Pacemaker, the world’s smallest pacemaker with atrioventricular (AV) synchrony. This device is used to treat AV block, a condition marked by impaired neural signals between atrial and ventricular chambers in the heart.

AV block can lead to irregular beat, and in some cases, increased risk of heart attack and complete heart block. It is normally treated with dual-chamber pacemakers in the upper chest, which are attached to the heart using “leads”, thin connective wires. Medtronic is the first to offer CE mark approved leadless pacemakers.

The Micra AV is part of the Micra Transcatheter Pacing Systems, which provide minimally invasive pacemaker options, as they are approximately one-tenth of the size of other devices. They do not require leads, which reduces the likelihood of complications after implanting the device, and reduces the visibility of the device under the skin. It works to treat AV block by monitoring the heart’s movement using an accelerometer, and continuously adjusting the pace of the ventricle.

This device was first implanted by Dr. José Ramón González Juanatey at University Hospital in Santiago de Compostela, Spain. Dr. Juanatey is the director of the cardiology and intensive cardiac care department at the University Hospital.

Speaking on the Micra AV, he said:

“For physicians, receiving accurate monitoring data and having remote access to programming provides the opportunity to operate with more efficiency and confidence. The LUX-Dx ICM System is designed to provide physicians the ability to accelerate critical clinical decisions and allow them to spend more time focusing on patient outcomes by reviewing monitoring data and catching false positive detections without compromising sensitivity.”

Via: Medtronic

For Further Information

This recent development presents interesting implications for the future of the cardiology market. iData Research’s Cardiac Rhythm Management Market Analysis, Size, Trends | Global | 2019-2025 | MedSuite contains a detailed international market analysis, including in-depth interviews and procedural volumes.